Perrigo (PRGO) Non-Current Debt (2013 - 2026)
Perrigo (PRGO) reported Non-Current Debt of $3.6 billion for Q1 2026, up 0.83% year-over-year from $3.6 billion in Q1 2025, and little changed quarter-over-quarter from $3.6 billion in Q4 2025.
Perrigo (PRGO) Non-Current Debt (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Non-Current Debt data on file, last reported at $3.6 billion in Q1 2026.
- Non-Current Debt for Q1 2026 came in at $3.6 billion, up 0.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 billion (up 0.83% YoY), and the FY2025 annual result was $3.6 billion, up 0.61% from the prior year.
- Non-Current Debt steadied at $3.6 billion in Q1 2026 per PRGO's latest filing, from $3.6 billion in the prior quarter.
- Over five years, Non-Current Debt peaked at $4.3 billion in Q3 2024 and troughed at $3.5 billion in Q2 2022.
- A 5-year average of $3.8 billion and a median of $3.6 billion in 2024 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2022 and 2025: Non-Current Debt soared 39.66% in 2022, then declined 16.34% in 2025.
- A 5-year view of Non-Current Debt shows it stood at $4.1 billion in 2022, then declined by 10.75% to $3.6 billion in 2023, then declined by 1.41% to $3.6 billion in 2024, then climbed by 0.61% to $3.6 billion in 2025, then grew by 0.49% to $3.6 billion in 2026.
- Business Quant data shows PRGO's Non-Current Debt at $3.6 billion in Q1 2026, $3.6 billion in Q4 2025, and $3.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn | 3.62 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 3.62 Bn |
| Mar 28, 2026 | 3.62 Bn |
| Dec 31, 2025 | 3.60 Bn |
| Dec 31, 2025 | 3.60 Bn |
| Sep 27, 2025 | 3.61 Bn |
| Sep 27, 2025 | 3.61 Bn |
| Jun 28, 2025 | 3.62 Bn |
| Jun 28, 2025 | 3.62 Bn |
| Mar 29, 2025 | 3.59 Bn |
| Mar 29, 2025 | 3.59 Bn |
| Dec 31, 2024 | 3.58 Bn |
| Dec 31, 2024 | 3.58 Bn |
| Sep 28, 2024 | 4.31 Bn |
| Sep 28, 2024 | 4.31 Bn |
| Jun 29, 2024 | 3.62 Bn |
| Jun 29, 2024 | 3.62 Bn |
| Mar 30, 2024 | 3.62 Bn |
| Mar 30, 2024 | 3.62 Bn |
| Dec 31, 2023 | 3.63 Bn |
| Dec 31, 2023 | 3.63 Bn |